December 9, 2022
Trending Tags

Sustainable business practice is a key focus of CPhI 2022

Read Time:3 Minute, 20 Second

“The pharma industry can make a hugely positive impact on our environment if we develop innovative solutions to manufacturing practices and if we think in a more agile and solutions-based approach,” ​say the organizers.

The CDMO perspective

James Choi, executive vice president, chief information and marketing officer, Samsung Biologics, will be speaking at the trade event about why pharmaceutical CDMO companies should make their transition with long-term sustainability in mind.

He will explain how the pharmaceutical industry and innovative initiatives should put effort into improving outcomes for patients, employees, the environment, and the wider community. 

Many health systems have identified medicines as one of the largest single contributors to their carbon footprint, according to Aurelio Arias, engagement manager, Thought Leadership, IQVIA. His talk at the Frankfurt fair will evaluate the pharma industry’s carbon footprint and provide recommendations on what the sector can do to reduce emissions, meet environmental targets, and consequently open a new path to supporting human health.

Frank Roschangar, highly distinguished research fellow, IU Sustainability, Boehringer Ingelheim Pharmaceuticals, and Michael Umberto Luescher, process R&D chemist, Novartis Pharmaceuticals, are also weighing in on this topic.

They will speak about best practices in green chemistry metrics for evaluating the impact of waste in pharmaceutical drug substance manufacturing, and their limitations, in the context of API lifecycle assessment.



Source link

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post “Mitzi’s Abortion: A Saint’s Guide to Late-Term Politics and Medicine in America” opens this weekend | News 19 Daybreak
Next post Kara Winger was at peace with her javelin career. Then came the podium performances